美国乙肝疫苗公司破产,绊倒中国创新药企

健识局
Nov 22, 2024

11月15日,VBI Vaccines宣布:公司破产终止运营,将在全美范围内召回乙肝 疫苗 PreHevbrio。VBI是一家纳斯达克上市公司,PreHevbrio是其开发的一款第三代预防性成人乙肝疫苗,2021年11月登陆美国市场,是VBI 唯一一款上市产品。今年7月VBI 申请破产,意味着PreHevbrio也将成为无本之木。原本只是一则大洋彼岸的消息,却意外牵连到一家国内 创新药 公司。去年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10